E852-4741 Screening compound: 5-butyl-N-cyclopentyl-6-methyl-4-oxo-2-[4-(pyridin-2-yl)piperazine-1-carbonyl]-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazine-6-carboxamide

E852-4741 Screening compound: 5-butyl-N-cyclopentyl-6-methyl-4-oxo-2-[4-(pyridin-2-yl)piperazine-1-carbonyl]-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazine-6-carboxamide
E852-4741 Screening compound: 5-butyl-N-cyclopentyl-6-methyl-4-oxo-2-[4-(pyridin-2-yl)piperazine-1-carbonyl]-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazine-6-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E852-4741
5-butyl-N-cyclopentyl-6-methyl-4-oxo-2-[4-(pyridin-2-yl)piperazine-1-carbonyl]-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazine-6-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E852-4741

Molecular Formula

C27H37N7O3 (C27 H37 N7 O3)

Compound Name

5-butyl-N-cyclopentyl-6-methyl-4-oxo-2-[4-(pyridin-2-yl)piperazine-1-carbonyl]-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazine-6-carboxamide

IUPAC name

5-butyl-N-cyclopentyl-6-methyl-4-oxo-2-[4-(pyridin-2-yl)piperazine-1-carbonyl]-4H5H6H7H-pyrazolo[15-a]pyrazine-6-carboxamide

SMILES

CCCCN(C(C)(Cn(c1c2)nc2C(N(CC2)CCN2c2ncccc2)=O)C(NC2CCCC2)=O)C1=O

InChI

InChI=1S/C27H37N7O3/c1-3-4-13-33-25(36)22-18-21(24(35)32-16-14-31(15-17-32)23-11-7-8-12-28-23)30-34(22)19-27(33,2)26(37)29-20-9-5-6-10-20/h7-8,11-12,18,20H,3-6,9-10,13-17,19H2,1-2H3,(H,29,37)/t27-/m0/s1

InChI Key

UEDPFZIEOYKRCY-MHZLTWQESA-N

MDL Number (MFCD)

MFCD27602511

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

507.64

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

3.196

Distribution Coefficient, logD

3.187

Water Solubility, LogSw

-3.29

Polar Surface Area

82.506

Acid Dissociation Constant (pKa)

15.47

Base Dissociation Constant (pKb)

5.71

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

59.30

E852-4741 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Cyclic Ugi PPI Library (9586 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

Epigenetics Focused Set (26518 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with E852-4741 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E852-4741?
Check Price and Availability of E852-4741, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E852-4741 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E852-4741
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E852-4741
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E852-4741 available by request